Clinical Trial Update: A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of PF-03187207 in primary open-angle glaucoma or ocular hypertension completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• PF-03187207

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-08-27